NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer

Summary

This is a single institution, single arm phase I/II study of NBTXR3 with radiation therapy for stage I-III advanced non-small cell lung cancer patients who are not candidates for chemotherapy or surgical resection.

Timeline

Start

2026-03-27

Primary completion

2028-08-30

Completion

2030-08-30

Drugs

Indications